ARTICLE | Company News
NovAliX, Fondation Jerome Lejeune deal
September 19, 2011 7:00 AM UTC
NovAliX and the foundation partnered to develop small molecules against cystathionine beta-synthase ( CBS) to treat Trisomy 21. NovAliX will be responsible for development under the two-year deal, whi...